Lineage Cell Therapeutics Inc. — Director's Dealing 2016

Jun 26, 2016

FORM 4
-----------	--

[ ] Check this box if no longer subject to Section 16. Form 4 or continue. See Instruction 1(b).

FORM 4 Washington, D.C. 20549

OMB Number: 3235-0287 Estimated average burden hours per response... 0.5

Form 5 obligations may UNITED STATES SECURITIES AND EXCHANGE COMMISSION STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES OMB APPROVAL

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person *	2. Issuer Name and Ticker or Trading Symbol	5. Relationship of Reporting Person(s) to Issuer
		(Check all applicable)
BROADWOOD PARTNERS LP	BIOTIME INC [ BTX ]
(Last) (First) (Middle)	3. Date of Earliest Transaction (MM/DD/YYYY)	__ X __ Director __ X __ 10% Owner
		_ Officer (give title below) ___ Other (specify below)
C/O BROADWOOD CAPITAL	6/21/2016
INC., 724 FIFTH AVENUE, 9TH
FLOOR
(Street)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line)
NEW YORK, NY 10019		___ Form filed by One Reporting Person
(City) (State) (Zip)		_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)				2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form:	7. Nature of Indirect Beneficial
						Code	V	Amount	(A) or (D)	Price		Direct (D) or Indirect (I) (Instr. 4)	Ownership (Instr. 4)
Common Stock				6/21/2016		P		2732636	A	\$2.39	24897032	D (1)
Common Stock				6/21/2016		P		0	A	\$0	24897032	I	See Footnote (2)
Common Stock											62908	D (3)
1. Title of Derivate	2.	3. Trans.	Table II - Derivative Securities Beneficially Owned ( e.g. 3A. Deemed	4. Trans. Code	5. Number of			6. Date Exercisable and			, puts, calls, warrants, options, convertible securities) 7. Title and Amount of 8. Price of 9. Number of	10.	11. Nature

Security (Instr. 3)	Conversion or Exercise	Date	Execution Date, if any	(Instr. 8)		Derivative Securities Acquired (A) or		Expiration Date			Securities Underlying Derivative Security	Derivative Security	derivative Securities	Ownership Form of	of Indirect Beneficial
	Price of Derivative Security					Disposed of (D) (Instr. 3, 4 and 5)		Date	Expiration	Title	(Instr. 3 and 4) Amount or Number of	(Instr. 5)	Beneficially Owned Following Reported Transaction(s)	Derivative Security: Direct (D) or Indirect (I) (Instr.	Ownership (Instr. 4)
				Code	V	(A)	(D)	Exercisable	Date		Shares		(Instr. 4)	4)

Explanation of Responses:

• ( 1) These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
• ( The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General
• 2) Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
• ( 3) These securities are owned by Neal C. Bradsher, who is a Reporting Person.

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% OwnerOfficerOther
BROADWOOD PARTNERS LP C/O BROADWOOD CAPITAL INC. 724 FIFTH AVENUE, 9TH FLOOR NEW YORK, NY 10019	X	X
BROADWOOD CAPITAL INC 724 FIFTH AVENUE, 9TH FLOOR NEW YORK, NY 10019		X
BRADSHER NEAL C

Signatures

Broadwood Partners, L.P., By Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	6/23/2016
** Signature of Reporting Person	Date
Broadwood Capital, Inc., By: /s/ Neal C. Bradsher, President	6/23/2016
** Signature of Reporting Person	Date
/s/ Neal C. Bradsher	6/23/2016
** Signature of Reporting Person	Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.